메뉴 건너뛰기




Volumn 10, Issue 18, 2004, Pages 2239-2248

The use of antiparkinsonian agents in the management of drug-induced extrapyramidal symptoms

Author keywords

Antiparkinsonian agents; Controversies regarding the long term use of anticholinergic drugs; Side effects of antiparkinsonian drugs; Treatment of drug induced extrapyramidal symptoms

Indexed keywords

AMANTADINE; ANTIPARKINSON AGENT; ATENOLOL; ATYPICAL ANTIPSYCHOTIC AGENT; BENZATROPINE; BENZATROPINE MESILATE; BENZODIAZEPINE; BENZOIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BIPERIDEN; CAFFEINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIAZEPAM; DIPHENHYDRAMINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; LORAZEPAM; METOPROLOL; METOPROLOL TARTRATE; NADOLOL; NEUROLEPTIC AGENT; OLANZAPINE; PINDOLOL; PROCYCLIDINE; PROPRANOLOL; QUETIAPINE; RISPERIDONE; SOTALOL; TRIHEXYPHENIDYL; UNINDEXED DRUG;

EID: 3042646544     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612043384123     Document Type: Review
Times cited : (31)

References (95)
  • 1
    • 0023747883 scopus 로고
    • Neuroleptic side effects: Acute extrapyramidal syndromes and tardive dyskinesia
    • Casey DE, Christensen AV Eds, Berlin, Springer
    • Casey DE, Keepers GA. Neuroleptic side effects: acute extrapyramidal syndromes and tardive dyskinesia. In: Casey DE, Christensen AV Eds, Psychopharmacology: current trends. Berlin, Springer 1988; 74-93.
    • (1988) Psychopharmacology: Current Trends , pp. 74-93
    • Casey, D.E.1    Keepers, G.A.2
  • 2
    • 0015684611 scopus 로고
    • Exacerbation of psychopathology during treatment: Etiology
    • Ananth JV and Brahm E. Exacerbation of psychopathology during treatment: etiology. Compr Psychiatry 1973; 14: 563-568.
    • (1973) Compr. Psychiatry , vol.14 , pp. 563-568
    • Ananth, J.V.1    Brahm, E.2
  • 3
    • 0028296475 scopus 로고
    • Motor and mental aspects of acute extrapyramidal syndromes
    • Casey DE. Motor and mental aspects of acute extrapyramidal syndromes. Acta Psychiatr Scand 1994; 89(suppl 380): 14-20.
    • (1994) Acta Psychiatr. Scand. , vol.89 , Issue.SUPPL. 380 , pp. 14-20
    • Casey, D.E.1
  • 4
    • 0035014928 scopus 로고    scopus 로고
    • Antipsychotic polypharmacy: A survey of discharge prescriptions from a tertiary care Psychiatric institution
    • Procyshyn RM, Kennedy NB, Tse G, Thompson B. Antipsychotic polypharmacy: A survey of discharge prescriptions from a tertiary care Psychiatric institution. Can J Psychiatry 2001; 46: 334-339.
    • (2001) Can. J. Psychiatry , vol.46 , pp. 334-339
    • Procyshyn, R.M.1    Kennedy, N.B.2    Tse, G.3    Thompson, B.4
  • 5
    • 0032909923 scopus 로고    scopus 로고
    • Pharmacologic and pharmacokinetic considerations in choosing an antipsychotic
    • Ereshefsky L. Pharmacologic and pharmacokinetic considerations in choosing an antipsychotic J Clin Psychiatry 1999; 60(suppl 10): 20-30.
    • (1999) J. Clin. Psychiatry , vol.60 , Issue.SUPPL. 10 , pp. 20-30
    • Ereshefsky, L.1
  • 6
    • 0343207778 scopus 로고
    • Five year study of benztropine (Cogentin) methanesulfonate: Outcome in three hundred two cases of paralysis agitans
    • Doshay LJ. Five year study of benztropine (Cogentin) methanesulfonate: outcome in three hundred two cases of paralysis agitans. JAMA 1956; 162: 1031-1034.
    • (1956) JAMA , vol.162 , pp. 1031-1034
    • Doshay, L.J.1
  • 7
    • 0000046430 scopus 로고
    • Treatment in internal medicine: The management of Parkinson's disease
    • England AC Jr, Schwab RS. Treatment in internal medicine: the management of Parkinson's disease. AMA Arch Intern Med 1959; 104: 439-468.
    • (1959) AMA Arch. Intern. Med. , vol.104 , pp. 439-468
    • England Jr., A.C.1    Schwab, R.S.2
  • 8
    • 0023155125 scopus 로고
    • Trihexyphenidyl abuse: Therapeutic implications for negative symptoms of schizophrenia?
    • Fish RZ. Trihexyphenidyl abuse: therapeutic implications for negative symptoms of schizophrenia? Acta Psychiatr Scand 1987; 75: 91-94.
    • (1987) Acta Psychiatr. Scand. , vol.75 , pp. 91-94
    • Fish, R.Z.1
  • 10
    • 3042591944 scopus 로고
    • Kemadrin in the treatment of parkinsonism
    • Schwab RS, Chafetz ME. Kemadrin in the treatment of parkinsonism. Neurology 1955; 5: 273-277.
    • (1955) Neurology , vol.5 , pp. 273-277
    • Schwab, R.S.1    Chafetz, M.E.2
  • 13
    • 0021037217 scopus 로고
    • Role of amantadine in the management of neuroleptic-induced extrapyramidal syndromes: Overview and pharmacology
    • Allen RM. Role of amantadine in the management of neuroleptic-induced extrapyramidal syndromes: overview and pharmacology. Clin Neuropharmacol 1983; 6(suppl 1): 64-73.
    • (1983) Clin. Neuropharmacol. , vol.6 , Issue.SUPPL. 1 , pp. 64-73
    • Allen, R.M.1
  • 15
    • 0029414763 scopus 로고
    • Twenty five years of amantadine therapy in Parkinson's disease
    • Danielczyk W. Twenty five years of amantadine therapy in Parkinson's disease. J Neural Transm 1995; Suppl 46: 399-405.
    • (1995) J. Neural Transm. , Issue.SUPPL. 46 , pp. 399-405
    • Danielczyk, W.1
  • 16
    • 0026751312 scopus 로고
    • Amantadine as N-Methyl-D-Aspartate acid receptor antagonist: New possibilities for therapeutic applications?
    • Stoof JC, Booij J, Drukarch B. Amantadine as N-Methyl-D-Aspartate acid receptor antagonist: new possibilities for therapeutic applications? Clin Neurol Neurosurg 1992; 94: S4-S6.
    • (1992) Clin. Neurol. Neurosurg. , vol.94
    • Stoof, J.C.1    Booij, J.2    Drukarch, B.3
  • 17
    • 0014939890 scopus 로고
    • Amantadine-dopamine interaction: Possible mode of action in parkinsonism
    • Grelak RP, Clark R, Stump JM, Vernier VG. Amantadine-dopamine interaction: possible mode of action in parkinsonism. Science 1970; 169: 203-204.
    • (1970) Science , vol.169 , pp. 203-204
    • Grelak, R.P.1    Clark, R.2    Stump, J.M.3    Vernier, V.G.4
  • 19
    • 0023697460 scopus 로고
    • Noradrenergic effects in tardive dyskinesia, akathisia and pseudoparkinsonism via the limbic system and basal ganglia
    • Wilbur R, Kulik FA, Kulik AV. Noradrenergic effects in tardive dyskinesia, akathisia and pseudoparkinsonism via the limbic system and basal ganglia. Prog Neuropsychopharmacol Biol Psychiatry 1988; 12: 849-864.
    • (1988) Prog. Neuropsychopharmacol. Biol. Psychiatry , vol.12 , pp. 849-864
    • Wilbur, R.1    Kulik, F.A.2    Kulik, A.V.3
  • 20
    • 0025875851 scopus 로고
    • Studies on the time course and efficacy of beta-blockers in neuroleptic-induced akathisia and the akathisia of idiopathic Parkinson's disease
    • Adler LA, Angrist B, Weinreb H, Rotrosen J. Studies on the time course and efficacy of beta-blockers in neuroleptic-induced akathisia and the akathisia of idiopathic Parkinson's disease. Psychopharmacol Bull 1991; 27: 107-111.
    • (1991) Psychopharmacol. Bull. , vol.27 , pp. 107-111
    • Adler, L.A.1    Angrist, B.2    Weinreb, H.3    Rotrosen, J.4
  • 21
    • 0023472847 scopus 로고
    • Lipophilicity, hydrophylicity, and the central nervous system side effects of beta-blockers
    • Drayer DE. Lipophilicity, hydrophylicity, and the central nervous system side effects of beta-blockers. Pharmacotherapy 1987; 7:87-91.
    • (1987) Pharmacotherapy , vol.7 , pp. 87-91
    • Drayer, D.E.1
  • 22
    • 0023553727 scopus 로고
    • Comparison of pharmacokinetic properties of beta-adrenoceptor blocking drugs
    • McDewitt DG. Comparison of pharmacokinetic properties of beta-adrenoceptor blocking drugs. Eur Heart J 1987; 8(suppl M): 9-14.
    • (1987) Eur. Heart J. , vol.8 , Issue.SUPPL. M , pp. 9-14
    • McDewitt, D.G.1
  • 23
    • 0027365770 scopus 로고
    • Serum iron abnormalities in neuroleptic-induced akathisia in schizophrenic patients
    • Soni SD, Tench D, Routledge RC. Serum iron abnormalities in neuroleptic-induced akathisia in schizophrenic patients. Br J Psychiatry 1993; 163: 669-72.
    • (1993) Br. J. Psychiatry , vol.163 , pp. 669-672
    • Soni, S.D.1    Tench, D.2    Routledge, R.C.3
  • 25
    • 0023253865 scopus 로고
    • Low serum iron status and akathisia
    • Brown KW, Glen SE, White T. Low serum iron status and akathisia. Lancet 1987; 1(8544): 1234-6.
    • (1987) Lancet , vol.1 , Issue.8544 , pp. 1234-1236
    • Brown, K.W.1    Glen, S.E.2    White, T.3
  • 26
    • 0009676668 scopus 로고
    • Neuroleptic induced acute dystonia
    • Lang AE, Weiner WJ Eds, Mount Kisko, Futura
    • Casey DE. Neuroleptic induced acute dystonia. In: Lang AE, Weiner WJ Eds, Drug-induced movement disorders. Mount Kisko, Futura 1992; 21-40.
    • (1992) Drug-induced Movement Disorders , pp. 21-40
    • Casey, D.E.1
  • 28
    • 0015278467 scopus 로고
    • The rabbit syndrome: A peculiar extrapyramidal reaction
    • Villeneuve A. The rabbit syndrome: a peculiar extrapyramidal reaction. Can Psychiatr Assoc J 1972; 17: 69-72.
    • (1972) Can. Psychiatr. Assoc. J. , vol.17 , pp. 69-72
    • Villeneuve, A.1
  • 29
    • 0019473480 scopus 로고
    • The differential diagnosis of tardive dyskinesia
    • Casey DE. The differential diagnosis of tardive dyskinesia. Acta Psychiatr Scand 1981; 63(suppl 291): 71-87.
    • (1981) Acta Psychiatr. Scand. , vol.63 , Issue.SUPPL. 291 , pp. 71-87
    • Casey, D.E.1
  • 32
    • 0021929136 scopus 로고
    • Spontaneous and tardive dyskinesias: Clinical and laboratory studies
    • Apr
    • Casey DE. Spontaneous and tardive dyskinesias: clinical and laboratory studies. J Clin Psychiatry 1985 Apr; 46(4 pt 2): 42-7.
    • (1985) J. Clin. Psychiatry , vol.46 , Issue.4 PART 2 , pp. 42-47
    • Casey, D.E.1
  • 33
    • 3042551763 scopus 로고
    • Paradoxical tardive dyskinesia
    • Joseph AB, Young RR Eds, Boston, Blackwell
    • Casey DE. Paradoxical tardive dyskinesia. In: Joseph AB, Young RR Eds, Movement disorders of neurology and neuropsychiatry. Boston, Blackwell 1992; 67-69.
    • (1992) Movement Disorders of Neurology and Neuropsychiatry , pp. 67-69
    • Casey, D.E.1
  • 34
    • 0017654351 scopus 로고
    • Pharmacological characterization of tardive dyskinesia
    • Casey DE, Denny D. Pharmacological characterization of tardive dyskinesia. Psychopharmacology 1977; 54: 1-8.
    • (1977) Psychopharmacology , vol.54 , pp. 1-8
    • Casey, D.E.1    Denny, D.2
  • 35
    • 0015966498 scopus 로고
    • Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia
    • Gerlach J, Reisby N, Randrup A. Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia. Psychopharmacology 1974; 34: 21-35.
    • (1974) Psychopharmacology , vol.34 , pp. 21-35
    • Gerlach, J.1    Reisby, N.2    Randrup, A.3
  • 36
    • 0003408017 scopus 로고
    • Tardive Dyskinesia: A Task Force Report of the American Psychiatric Association
    • American Psychiatric Association. Task Force on Tardive Dyskinesia. Washington, DC, American Psychiatric Association
    • American Psychiatric Association. Task Force on Tardive Dyskinesia. Tardive Dyskinesia: a Task Force Report of the American Psychiatric Association. Washington, DC, American Psychiatric Association 1992.
    • (1992)
  • 37
    • 0029907320 scopus 로고    scopus 로고
    • Negative symptoms, congnitive dysfunction tardive akathisia and tardive dyskinesia
    • Sachdev P, Hume F, Toohey P, Doutney C. Negative symptoms, congnitive dysfunction tardive akathisia and tardive dyskinesia. Acta Psychiatr Scand 1996; 91: 451-459.
    • (1996) Acta Psychiatr. Scand. , vol.91 , pp. 451-459
    • Sachdev, P.1    Hume, F.2    Toohey, P.3    Doutney, C.4
  • 44
    • 0025975251 scopus 로고
    • Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia
    • Casey DE. Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia. Schizophr Res 1991; 4: 109-120.
    • (1991) Schizophr. Res. , vol.4 , pp. 109-120
    • Casey, D.E.1
  • 45
    • 3042589822 scopus 로고    scopus 로고
    • Treatment of extrapyramidal side effects
    • Schatzberg AF, Nemeroff CB Eds, Washington, DC, American Psychiatric Publishing, Inc
    • Stanilla JK, Simpson GM. Treatment of extrapyramidal side effects. In: Schatzberg AF, Nemeroff CB Eds, Essentials of Clinical Psychopharmacology. Washington, DC, American Psychiatric Publishing, Inc. 2001; 155-182.
    • (2001) Essentials of Clinical Psychopharmacology , pp. 155-182
    • Stanilla, J.K.1    Simpson, G.M.2
  • 46
    • 0009026129 scopus 로고
    • Adverse psychotropic drug-drug interactions
    • Kane JM, Lieberman JA Eds, New York, Guilford
    • Leipzig RM, Mendelowitz A. Adverse psychotropic drug-drug interactions. In: Kane JM, Lieberman JA Eds, Adverse Effects of Psychotropic Drugs. New York, Guilford 1992; 13-76.
    • (1992) Adverse Effects of Psychotropic Drugs , pp. 13-76
    • Leipzig, R.M.1    Mendelowitz, A.2
  • 47
    • 0021053879 scopus 로고
    • The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs
    • McEvoy JP. The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs. J Clin Psychopharmacol 1983; 3: 288-302.
    • (1983) J. Clin. Psychopharmacol. , vol.3 , pp. 288-302
    • McEvoy, J.P.1
  • 48
    • 0028998465 scopus 로고
    • Interactions between antipsychotic and antihypertensive drugs
    • Jun
    • Markowitz JS, Wells BG, Carson WH. Interactions between antipsychotic and antihypertensive drugs. Ann Pharmacother 1995 Jun; 29(6): 603-9.
    • (1995) Ann. Pharmacother. , vol.29 , Issue.6 , pp. 603-609
    • Markowitz, J.S.1    Wells, B.G.2    Carson, W.H.3
  • 49
    • 0015177350 scopus 로고
    • Complications of psychotropic medications in high dosage
    • Warnes H, Ananth JV. Complications of psychotropic medications in high dosage. Psychiatr Q 1971; 45: 87-92.
    • (1971) Psychiatr. Q. , vol.45 , pp. 87-92
    • Warnes, H.1    Ananth, J.V.2
  • 50
    • 12244279032 scopus 로고    scopus 로고
    • Effect of acute procyclidine administration on prepulse inhibition of the startle response in schizophrenia: A double blind placebo controlled study
    • Kumari V, Zachariah E, Galea A, Jones HC, Das M, Mehotra R, et al. Effect of acute procyclidine administration on prepulse inhibition of the startle response in schizophrenia: a double blind placebo controlled study. J Psychopharmacol 17: 89-95, 2003.
    • (2003) J. Psychopharmacol. , vol.17 , pp. 89-95
    • Kumari, V.1    Zachariah, E.2    Galea, A.3    Jones, H.C.4    Das, M.5    Mehotra, R.6
  • 51
    • 0023885592 scopus 로고
    • Differential memory function with dopaminergic versus anticholinergic treatment of drug induced extrapyramidal symptoms
    • Fayen M, Goldman MB, Moulthrop MA, Luchins DJ. Differential memory function with dopaminergic versus anticholinergic treatment of drug induced extrapyramidal symptoms. Am J Psychiatry 1988; 145: 483-486.
    • (1988) Am. J. Psychiatry , vol.145 , pp. 483-486
    • Fayen, M.1    Goldman, M.B.2    Moulthrop, M.A.3    Luchins, D.J.4
  • 52
    • 0025914326 scopus 로고
    • Relationhsips between medication treatments and neuropsychological test performance in schizophrenia
    • Sweeney JA, Keilp JG, Haas GL, Hill J, Weiden PJ. Relationhsips between medication treatments and neuropsychological test performance in schizophrenia. Psychiatry Res 1991; 37: 297-308.
    • (1991) Psychiatry Res. , vol.37 , pp. 297-308
    • Sweeney, J.A.1    Keilp, J.G.2    Haas, G.L.3    Hill, J.4    Weiden, P.J.5
  • 53
    • 0033118149 scopus 로고    scopus 로고
    • Neuroleptic induced extrapyramidal symptoms are accompanied by cognitive dysfunction in schizophrenia
    • Krausz M, Moritz SH, Naber D, Lambert M, Andresen B. Neuroleptic induced extrapyramidal symptoms are accompanied by cognitive dysfunction in schizophrenia. Eur Psychiatry 1999; 14: 84-88.
    • (1999) Eur. Psychiatry , vol.14 , pp. 84-88
    • Krausz, M.1    Moritz, S.H.2    Naber, D.3    Lambert, M.4    Andresen, B.5
  • 54
    • 0018913664 scopus 로고
    • Adverse effects of anticholinergic antiparkinsonian drugs in tardive dyskinesia. An investigation of mechanism
    • Burnett GB, Prange AJ Jr, Wilson IC, Joliff LA, Creese IC, Synder SH. Adverse effects of anticholinergic antiparkinsonian drugs in tardive dyskinesia. An investigation of mechanism. Neuropsychobiology 1980; 6(2): 109-20.
    • (1980) Neuropsychobiology , vol.6 , Issue.2 , pp. 109-120
    • Burnett, G.B.1    Prange Jr., A.J.2    Wilson, I.C.3    Joliff, L.A.4    Creese, I.C.5    Synder, S.H.6
  • 55
    • 0020352791 scopus 로고
    • Type I tardive dyskinesia induced by anticholinergic drugs, dopamine agonists and neuroleptics
    • Chouinard G, Steinberg S. Type I tardive dyskinesia induced by anticholinergic drugs, dopamine agonists and neuroleptics. Prog Neuropsychopharmacol Biol Psychiatry 1982; 6(4-6): 571-8.
    • (1982) Prog. Neuropsychopharmacol. Biol. Psychiatry , vol.6 , Issue.4-6 , pp. 571-578
    • Chouinard, G.1    Steinberg, S.2
  • 56
    • 0033782696 scopus 로고    scopus 로고
    • Abuse potential of anticholinergics
    • Dose M, Tempal HD. Abuse potential of anticholinergics. Pharmacopsychiatry 2000, 33(suppl 1): 43-46.
    • (2000) Pharmacopsychiatry , vol.33 , Issue.SUPPL. 1 , pp. 43-46
    • Dose, M.1    Tempal, H.D.2
  • 59
    • 0022445363 scopus 로고
    • Anticholinergic agents in the prophylaxis of neuroleptic induced dystonic reactions: A prospective study
    • Sramek JJ, Simpson GM, Morrison RL, Heiser JF. Anticholinergic agents in the prophylaxis of neuroleptic induced dystonic reactions: a prospective study. J Clin Psychiatry 1986; 47: 305-309.
    • (1986) J. Clin. Psychiatry , vol.47 , pp. 305-309
    • Sramek, J.J.1    Simpson, G.M.2    Morrison, R.L.3    Heiser, J.F.4
  • 60
    • 0026085963 scopus 로고
    • Use of neuroleptic-induced extrapyramidal symptoms to predict future vulnerability to side effects
    • Keepers GA, Casey DE. Use of neuroleptic-induced extrapyramidal symptoms to predict future vulnerability to side effects. Am J Psychiatry 1991; 148: 85-89.
    • (1991) Am. J. Psychiatry , vol.148 , pp. 85-89
    • Keepers, G.A.1    Casey, D.E.2
  • 61
    • 0020629612 scopus 로고
    • Initial anticholinergic prophylaxis for neuroleptic-induced extrapyramidal syndromes
    • Keepers GA, Clappison VJ, Casey DE. Initial anticholinergic prophylaxis for neuroleptic-induced extrapyramidal syndromes. Arch Gen Psychiatry 1983; 40: 1113-1117.
    • (1983) Arch. Gen. Psychiatry , vol.40 , pp. 1113-1117
    • Keepers, G.A.1    Clappison, V.J.2    Casey, D.E.3
  • 62
    • 0018762596 scopus 로고
    • Benztropine prophylaxis of dystonic reactions
    • Stern TA, Anderson WH. Benztropine prophylaxis of dystonic reactions. Psychopharmacologia 1979; 61: 261-262.
    • (1979) Psychopharmacologia , vol.61 , pp. 261-262
    • Stern, T.A.1    Anderson, W.H.2
  • 63
    • 0020374194 scopus 로고
    • Extrapyramidal side effects and oral haloperidol: An analysis of explanatory patient and treatment characteristics
    • Moleman P, Schmitz PSM, Ladee GA. Extrapyramidal side effects and oral haloperidol: An analysis of explanatory patient and treatment characteristics. J Clin Psychiatry 1982; 43: 492-496.
    • (1982) J. Clin. Psychiatry , vol.43 , pp. 492-496
    • Moleman, P.1    Schmitz, P.S.M.2    Ladee, G.A.3
  • 64
    • 0014842629 scopus 로고
    • Effect of withdrawal of antiparkinsonian medication on chronically hospitalized psychiatric patients
    • 1970
    • Ananth JV, Horodesky S, Lehmann HE, Ban TA. Effect of withdrawal of antiparkinsonian medication on chronically hospitalized psychiatric patients. Laval Med 1970; 41: 934-938, 1970.
    • (1970) Laval Med. , vol.41 , pp. 934-938
    • Ananth, J.V.1    Horodesky, S.2    Lehmann, H.E.3    Ban, T.A.4
  • 65
    • 0017641717 scopus 로고
    • Extrapyramidal side effects in chlorpromazine recipients: Emergence according to benztropine prophylaxis
    • Swett C Jr, Cole JO, Shapiro S, Slone D. Extrapyramidal side effects in chlorpromazine recipients: emergence according to benztropine prophylaxis. Arch Gen Psychiatry 1977; 34(8): 942-3.
    • (1977) Arch. Gen. Psychiatry , vol.34 , Issue.8 , pp. 942-943
    • Swett Jr., C.1    Cole, J.O.2    Shapiro, S.3    Slone, D.4
  • 66
    • 0014880158 scopus 로고
    • Antiparkinsonian drug overuse
    • DiMascio A, Demirgian E. Antiparkinsonian drug overuse. Psychosomatics 1970; 11: 596-601.
    • (1970) Psychosomatics , vol.11 , pp. 596-601
    • DiMascio, A.1    Demirgian, E.2
  • 67
    • 3042642574 scopus 로고
    • Reversibility of drug induced parkinsonism
    • Cahan RB, Parrish DD. Reversibility of drug induced parkinsonism. Am J Psychiatry 1960; 116: 1022-1023.
    • (1960) Am. J. Psychiatry , vol.116 , pp. 1022-1023
    • Cahan, R.B.1    Parrish, D.D.2
  • 68
    • 0017086537 scopus 로고
    • Comparison of benztropine mesylate and amantadine HCl in neuroleptic induced extrapyramidal symptoms
    • Stenson RL, Donlon PT, Meyer JE. Comparison of benztropine mesylate and amantadine HCl in neuroleptic induced extrapyramidal symptoms. Compr Psychiatry 1976; 17: 763-768.
    • (1976) Compr. Psychiatry , vol.17 , pp. 763-768
    • Stenson, R.L.1    Donlon, P.T.2    Meyer, J.E.3
  • 69
    • 0015323715 scopus 로고
    • Evaluating the long term need for antiparkinsoniuan drugs by chronic schizophrenics
    • Klett CJ, Point P, Caffey E. Evaluating the long term need for antiparkinsoniuan drugs by chronic schizophrenics. Arch Gen Psychiatry 1972; 26: 374-379.
    • (1972) Arch. Gen. Psychiatry , vol.26 , pp. 374-379
    • Klett, C.J.1    Point, P.2    Caffey, E.3
  • 72
    • 0015108222 scopus 로고
    • Lack of indication for use of antiparkinson medication. A follow-up study
    • Aug
    • Pecknold JC, Ananth JV, Ban TA, Lehmann HE. Lack of indication for use of antiparkinson medication. A follow-up study. Dis Nerv Syst 1971 Aug; 32(8): 538-41.
    • (1971) Dis. Nerv. Syst , vol.32 , Issue.8 , pp. 538-541
    • Pecknold, J.C.1    Ananth, J.V.2    Ban, T.A.3    Lehmann, H.E.4
  • 73
  • 74
    • 0020677739 scopus 로고
    • The abrupt withdrawal of antiparkinsonian drugs in mentally handicapped patients
    • Carter G. The abrupt withdrawal of antiparkinsonian drugs in mentally handicapped patients. Br J Psychiatry 1983; 142: 166-168.
    • (1983) Br. J. Psychiatry , vol.142 , pp. 166-168
    • Carter, G.1
  • 76
    • 0026005852 scopus 로고
    • Prophylactic antiparkinsonian druguse II, Withdrawal after long term maintenance therapy
    • Lavin MR, Rifkin A. Prophylactic antiparkinsonian druguse II, Withdrawal after long term maintenance therapy. J Clin Pharmacol 1991; 31: 769-777.
    • (1991) J. Clin. Pharmacol. , vol.31 , pp. 769-777
    • Lavin, M.R.1    Rifkin, A.2
  • 77
    • 0015969003 scopus 로고
    • Antiparkinsonian agents and depot phenothiazine
    • Chien CP, DiMascio A, Cole JO. Antiparkinsonian agents and depot phenothiazine. Am J Psychiatry 1974; 131: 86-90.
    • (1974) Am. J. Psychiatry , vol.131 , pp. 86-90
    • Chien, C.P.1    DiMascio, A.2    Cole, J.O.3
  • 78
    • 0013797455 scopus 로고
    • Treatment of phenothiazine induced parkinsonism with biperdin
    • Lapolla A, Nash LR. Treatment of phenothiazine induced parkinsonism with biperdin. Curr Ther Res Clin Exp 1965; 7: 536-541.
    • (1965) Curr. Ther. Res. Clin. Exp. , vol.7 , pp. 536-541
    • Lapolla, A.1    Nash, L.R.2
  • 79
    • 0032946164 scopus 로고    scopus 로고
    • Gradual withdrawal of long term anticholinergic antiparkinsonian medication in Chinese patients with chronic schizophrenia
    • Ungvari GS, Chui HF, Lam LC, Pang AH, Li SW, Leung T. Gradual withdrawal of long term anticholinergic antiparkinsonian medication in Chinese patients with chronic schizophrenia. J Clin Psychopharmacol 1999; 19: 141-148.
    • (1999) J. Clin. Psychopharmacol. , vol.19 , pp. 141-148
    • Ungvari, G.S.1    Chui, H.F.2    Lam, L.C.3    Pang, A.H.4    Li, S.W.5    Leung, T.6
  • 80
    • 0032973854 scopus 로고    scopus 로고
    • Managing antipsychotic induced parkinsonism
    • Mamo DC, Sweet RA, Keshavan MS. Managing antipsychotic induced parkinsonism. Drug Safety 1999; 20: 269-275.
    • (1999) Drug Safety , vol.20 , pp. 269-275
    • Mamo, D.C.1    Sweet, R.A.2    Keshavan, M.S.3
  • 82
    • 0029063672 scopus 로고
    • Antiparkinsonian drugs in neuroleptic teatment: Comparative study of progressive and abrupt withdrawal
    • Ali BH, Dogui M, Ammou BS, Loo H. Antiparkinsonian drugs in neuroleptic teatment:comparative study of progressive and abrupt withdrawal. Encephale 1995; 21: 209-215.
    • (1995) Encephale , vol.21 , pp. 209-215
    • Ali, B.H.1    Dogui, M.2    Ammou, B.S.3    Loo, H.4
  • 85
    • 0021739964 scopus 로고
    • A survey of prescribing of psychotropic drugs in a Birmingham psychiatric hospital
    • Edwards S, Kumar V. A survey of prescribing of psychotropic drugs in a Birmingham psychiatric hospital. Br J Psychiatry 1984; 145: 502-7.
    • (1984) Br. J. Psychiatry , vol.145 , pp. 502-507
    • Edwards, S.1    Kumar, V.2
  • 87
    • 0019858508 scopus 로고
    • Adverse effects of antiparkinson drug withdrawal
    • Jellinek T, Gardos G, Cole JO. Adverse effects of antiparkinson drug withdrawal. Am J Psychiatry 1981; 138: 1567-1571.
    • (1981) Am. J. Psychiatry , vol.138 , pp. 1567-1571
    • Jellinek, T.1    Gardos, G.2    Cole, J.O.3
  • 88
    • 0017398217 scopus 로고
    • Mood elevating effect of trihexyphenidyl and biperiden in individuals taking antipsychotic medication
    • Jellinelk T. Mood elevating effect of trihexyphenidyl and biperiden in individuals taking antipsychotic medication. Dis Nerv Syst 1977; 38(5): 353-5.
    • (1977) Dis. Nerv. Syst. , vol.38 , Issue.5 , pp. 353-355
    • Jellinelk, T.1
  • 89
    • 0018943605 scopus 로고
    • Abuse of the antiparkinson drugs: A review of the literature
    • Smith JM. Abuse of the antiparkinson drugs: a review of the literature. J Clin Psychiatry 1980; 41(10): 351-4.
    • (1980) J. Clin. Psychiatry , vol.41 , Issue.10 , pp. 351-354
    • Smith, J.M.1
  • 92
    • 0033759895 scopus 로고    scopus 로고
    • Insomnia related to biperidin withdrawal in two schizophrenic patients
    • Hirose S. Insomnia related to biperidin withdrawal in two schizophrenic patients. Int J Clin Psychopharmacol 2000; 15: 357-359.
    • (2000) Int. J. Clin. Psychopharmacol. , vol.15 , pp. 357-359
    • Hirose, S.1
  • 93
    • 0037278185 scopus 로고    scopus 로고
    • Progress in developing D3 dopamine receptor ligands as potential therapeutic agents for neurological and neuropsychiatric disorders
    • Luedtkea RR, Mach RH. Progress in developing D3 dopamine receptor ligands as potential therapeutic agents for neurological and neuropsychiatric disorders. Curr Pharm Design 2003; 9(8): 643-71.
    • (2003) Curr. Pharm. Design , vol.9 , Issue.8 , pp. 643-671
    • Luedtkea, R.R.1    Mach, R.H.2
  • 94
    • 0036250086 scopus 로고    scopus 로고
    • NR2B selective NMDA receptor antagonists
    • Nikam SS, Meltzer LT. NR2B selective NMDA receptor antagonists. Curr Pharm Design 2002; 8(10): 845-55.
    • (2002) Curr. Pharm. Design , vol.8 , Issue.10 , pp. 845-855
    • Nikam, S.S.1    Meltzer, L.T.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.